SCHEMBL12591

SCHEMBL12591

FC1CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL219848 0.95
Hydrochloric Acid SCHEMBL6688968 0.91
SCHEMBL31691604 0.88
SCHEMBL26125394 0.88
Hydrochloric Acid SCHEMBL27041312 0.84
Azetidine SCHEMBL6112493 0.84 CXCR4 (0.35)
Hydrochloric Acid SCHEMBL30988141 0.84
Hydrochloric Acid SCHEMBL32666817 0.84
SCHEMBL2450701 0.79
SCHEMBL10843679 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559481-B2 Quinoline derivatives ELANCO ANIMAL HEALTH GMBH (DE) 2026-02-24 US claimed
CN-112074514-B Quinoline derivatives 礼蓝动物保健有限公司 2024-10-29 CN claimed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 WO claimed
EP-4259606-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE Intervet International B.V. (NL) 2023-10-18 EP claimed
US-20230141809-A1 QUINOLINE DERIVATIVES ELANCO ANIMAL HEALTH GMBH (DE) 2023-05-11 US claimed
US-11612606-B2 8-aminoisoquinoline compounds and uses thereof GENENTECH, INC. (US) 2023-03-28 US claimed
EP-3790874-B1 ANTHELMINTIC QUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-03-15 EP claimed
CN-115710260-A Amide pyridine thiazole compound targeting GSK-3 beta, and preparation method and application thereof 重庆医科大学 2023-02-24 CN claimed
US-11572357-B2 Quinoline derivatives BAYER ANIMAL HEALTH GMBH (DE) 2023-02-07 US claimed
CN-114650995-A [1,4] oxazepine [2,3-C ] quinolinone derivatives as BCL6 inhibitors 癌症研究技术有限公司 2022-06-21 CN claimed
EP-2807159-A1 NEW INDOLIZINE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier (FR) 2014-12-03 EP claimed
WO-2014153037-A1 SUBSTITUTED TRIAZOLOPYRIDINES AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2014-09-25 WO claimed
US-20130317000-A1 N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF XENON PHARMACEUTICALS INC. (CA) 2013-11-28 US claimed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO claimed
US-20130317001-A1 N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF XENON PHARMACEUTICALS INC. (CA) 2013-11-28 US claimed
WO-2013110890-A1 NEW INDOLIZINE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2013-08-01 WO claimed
EP-2041141-A2 BENZOPYRANOPYRAZOLES 4SC AG (DE) 2009-04-01 EP claimed
WO-2008084067-A2 PHARMACEUTICALLY ACTIVE DIHYDROBENZOFURANE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES NYCOMED GMBH (DE) 2008-07-17 WO claimed
WO-2008071766-A2 SPIRO-INDENE SUBSTITUTED IMIDAZONAPHYTHYRIDINE AND PYRANOIMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF GASTRIC ACID SECRETION NYCOMED GMBH (DE) 2008-06-19 WO claimed
WO-2008006883-A2 BENZOPYRANOPYRAZOLES 4SC AG (DE) 2008-01-17 WO claimed